BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34003544)

  • 1. The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.
    Zuo Y; Qu C; Tian Y; Wen Y; Xia S; Ma M
    Biofactors; 2021 May; 47(3):444-460. PubMed ID: 34003544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
    Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
    Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.
    Mahajan M; Sitasawad S
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG1 alleviates OGD induced injury in BMEC via miR-338/HIF-1α axis.
    Yang X; Zi XH
    Brain Res; 2019 Jul; 1714():174-181. PubMed ID: 30414401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.
    Raimondi L; Amodio N; Di Martino MT; Altomare E; Leotta M; Caracciolo D; Gullà A; Neri A; Taverna S; D'Aquila P; Alessandro R; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2014 May; 5(10):3039-54. PubMed ID: 24839982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer.
    Li J; Zhang Z; Xiong L; Guo C; Jiang T; Zeng L; Li G; Wang J
    Biochem Biophys Res Commun; 2017 May; 487(1):146-152. PubMed ID: 28400279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma.
    Qu A; Yang Q
    Neoplasma; 2020 May; 67(3):557-566. PubMed ID: 32122143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway.
    Dai L; Lou W; Zhu J; Zhou X; Di W
    Int J Clin Exp Pathol; 2015; 8(5):4735-44. PubMed ID: 26191163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.
    Zhang N; Liu FL; Ma TS; Zhang ZZJ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8971-8983. PubMed ID: 31696485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway.
    Sun S; Ma J; Xie P; Wu Z; Tian X
    J Gene Med; 2020 Oct; 22(10):e3230. PubMed ID: 32436353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
    Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C
    Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
    Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
    Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2.
    Xiang W; Lyu L; Huang T; Zheng F; Yuan J; Zhang C; Jiang G
    J Cell Mol Med; 2020 Oct; 24(20):11858-11873. PubMed ID: 32885590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis.
    Huang R; Li J; Pan F; Zhang B; Yao Y
    Am J Transl Res; 2020; 12(1):32-44. PubMed ID: 32051735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.